BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 211580)

  • 21. [Demonstration of Epstein-Barr virus capsid antigen (VCA) in lymphocyte cultures from patients with mononucleosis].
    Szucs G; Ternák G
    Orv Hetil; 1977 Aug; 118(32):1891-2. PubMed ID: 196242
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of IgG-IgM antibodies against the Epstein-Barr virus nuclear antigen (EBNA-1) using ELISA].
    Martínez Zapico R; Sobejano L; Llamazares I; Ladrón de Guevara C
    Enferm Infecc Microbiol Clin; 1992 May; 10(5):281-3. PubMed ID: 1327168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
    Wingate PJ; McAulay KA; Anthony IC; Crawford DH
    J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
    Pearson G; Dewey F; Klein G; Henle G; Henle W
    J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of serological criteria for the diagnosis of infectious mononucleosis].
    de Ory F; Echevarría JM
    Enferm Infecc Microbiol Clin; 1989 Nov; 7(9):485-8. PubMed ID: 2562304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact.
    Gray J; Wreghitt TG; Pavel P; Smyth RL; Parameshwar J; Stewart S; Cary N; Large S; Wallwork J
    J Heart Lung Transplant; 1995; 14(4):640-6. PubMed ID: 7578169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus-specific serology in immunologically compromised individuals.
    Henle W; Henle G
    Cancer Res; 1981 Nov; 41(11 Pt 1):4222-5. PubMed ID: 6272966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The isolation of the antibody moieties of immune complexes from serum by the pepsin digestion of conglutinin-anti-conglutinin complexes.
    Lachmann PJ; Macanovic M; Harkiss GD; Oldroyd RG; Habicht J
    Clin Exp Immunol; 1981 Nov; 46(2):250-8. PubMed ID: 6279342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [IgA antibodies against Epstein-Barr virus capsid antigen].
    Chalupa P; Slesinger P; Krchnáková A; Prásek J
    Cas Lek Cesk; 1992 Sep; 131(17):526-9. PubMed ID: 1330312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of immune complexes in rheumatoid arthritis for Epstein-Barr virus antigens reveals cross-reactivity of viral capsid antigen and human IgG.
    Inman RD; Chiu B; Hamilton NC
    J Immunol; 1987 Jan; 138(2):407-12. PubMed ID: 3025298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serological diagnosis of infectious mononucleosis caused by Epstein-Barr virus].
    de Ory F
    Enferm Infecc Microbiol Clin; 1991 Jan; 9(1):63-4. PubMed ID: 1851444
    [No Abstract]   [Full Text] [Related]  

  • 32. [Determination of levels of specific antibodies against the Epstein-Barr virus using the ELISA method in infectious mononucleosis and its diagnostic significance].
    Ringelová J; Franc B
    Cesk Pediatr; 1983 Jan; 38(1):13-7. PubMed ID: 6297811
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibody responses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome.
    Sakamoto K; Freed HJ; Purtilo DT
    J Immunol; 1980 Aug; 125(2):921-5. PubMed ID: 6248598
    [No Abstract]   [Full Text] [Related]  

  • 34. Demonstration of EBNA (Epstein-Barr virus nuclear antigen) antibodies of different immunoglobulin classes.
    Czeglédy J; Gergely L; Váczi L; Szalka A
    Acta Microbiol Acad Sci Hung; 1978; 25(4):237-43. PubMed ID: 224651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of a dot-blot technique for the detection of Epstein-Barr virus antibodies (IgG anti-viral capsid antigen)].
    Bouillet L; Cattoen C; Keilani A; Chatelain C; Mazars E
    Ann Biol Clin (Paris); 1998; 56(1):79-83. PubMed ID: 9754226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioiodine-labeled antibody test for the detection of membrane antigens associated with Epstein-Barr virus.
    Hewetson JF; Gothoskar B; Klein G
    J Natl Cancer Inst; 1972 Jan; 48(1):87-94. PubMed ID: 4347031
    [No Abstract]   [Full Text] [Related]  

  • 38. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Circulating immune complexes in human leukemias].
    Carpentier NA; Zubler RH; Lange GT; Lambert PH; Miescher PA
    Schweiz Med Wochenschr; 1976 Oct; 106(40):1363-4. PubMed ID: 1070156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Present status of infectious mononucleosis and Epstein Barr virus].
    Ducroix JP; Smail A; Vovan AT; Devauchelle B; Baillet J
    LARC Med; 1984 Mar; 4(3):161-3. PubMed ID: 6325836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.